Delivery Order SPE2DB20D1100-SPE2DB24FC5C0

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,632.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of TRINTELLIX 5 MG TABLET 30S, a prescription medication, with a period of performance through April 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award for $7,459.10 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order for the supply of TRINTELLIX 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 27, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,309.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a performance period ending on May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Trintellix 20 mg tablets. The contract, valued at $2,147.31, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, valued at $4,346.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566210258 TRINTELLIX 5 MG TABLET 30S, with an ultimate completion date of October 28, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,703.11 Firm Fixed Price Delivery Order is for the supply of TRINTELLIX 20 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of September 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWV1) worth $1,510.80 for the supply of TRINTELLIX 10 MG TABLETs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award is for the supply of TRINTELLIX 5 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $3,139.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRINTELLIX 5 MG TABLET 30S. The contract has a firm fixed price of $1,087.09 and a performance period through June 26, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of the company's larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Trintellix 10 mg tablet 30s. The contract has a ceiling value of $1,014.58 and a period of performance through April 10, 2024. This award is a task order under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5C0
    Delivery Order

This federal contract award, with a ceiling value of $2,570.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs.

The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA. This IDC covers critical medical commodities across multiple therapeutic domains, enabling efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 9:52 AM